NCT02584933 2026-04-02
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Active not recruiting
Novartis
GT Medical Technologies, Inc.
University Hospital, Strasbourg, France
Monash University
Chang Gung Memorial Hospital
Oslo University Hospital